Beijing Science Sun Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 382.8 million compared to CNY 521.09 million a year ago. Revenue was CNY 383.34 million compared to CNY 521.93 million a year ago.

Net income was CNY 234.18 million compared to CNY 85.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.49 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.49 compared to CNY 0.18 a year ago.